Cargando…
Transcriptome integration analysis and specific diagnosis model construction for Hodgkin's lymphoma, diffuse large B-cell lymphoma, and mantle cell lymphoma
Transcriptome differences between Hodgkin's lymphoma (HL), diffuse large B-cell lymphoma (DLBCL), and mantle cell lymphoma (MCL), which are all derived from B cell, remained unclear. This study aimed to construct lymphoma-specific diagnostic models by screening lymphoma marker genes. Transcript...
Autores principales: | , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8109084/ https://www.ncbi.nlm.nih.gov/pubmed/33885377 http://dx.doi.org/10.18632/aging.202882 |
_version_ | 1783690190553874432 |
---|---|
author | Li, Wen-Xing Dai, Shao-Xing An, San-Qi Sun, Tingting Liu, Justin Wang, Jun Liu, Leyna G. Xun, Yang Yang, Hua Fan, Li-Xia Zhang, Xiao-Li Liao, Wan-Qin You, Hua Tamagnone, Luca Liu, Fang Huang, Jing-Fei Liu, Dahai |
author_facet | Li, Wen-Xing Dai, Shao-Xing An, San-Qi Sun, Tingting Liu, Justin Wang, Jun Liu, Leyna G. Xun, Yang Yang, Hua Fan, Li-Xia Zhang, Xiao-Li Liao, Wan-Qin You, Hua Tamagnone, Luca Liu, Fang Huang, Jing-Fei Liu, Dahai |
author_sort | Li, Wen-Xing |
collection | PubMed |
description | Transcriptome differences between Hodgkin's lymphoma (HL), diffuse large B-cell lymphoma (DLBCL), and mantle cell lymphoma (MCL), which are all derived from B cell, remained unclear. This study aimed to construct lymphoma-specific diagnostic models by screening lymphoma marker genes. Transcriptome data of HL, DLBCL, and MCL were obtained from public databases. Lymphoma marker genes were screened by comparing cases and controls as well as the intergroup differences among lymphomas. A total of 9 HL marker genes, 7 DLBCL marker genes, and 4 MCL marker genes were screened in this study. Most HL marker genes were upregulated, whereas DLBCL and MCL marker genes were downregulated compared to controls. The optimal HL-specific diagnostic model contains one marker gene (MYH2) with an AUC of 0.901. The optimal DLBCL-specific diagnostic model contains 7 marker genes (LIPF, CCDC144B, PRO2964, PHF1, SFTPA2, NTS, and HP) with an AUC of 0.951. The optimal MCL-specific diagnostic model contains 3 marker genes (IGLV3-19, IGKV4-1, and PRB3) with an AUC of 0.843. The present study reveals the transcriptome data-based differences between HL, DLBCL, and MCL, when combined with other clinical markers, may help the clinical diagnosis and prognosis. |
format | Online Article Text |
id | pubmed-8109084 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Impact Journals |
record_format | MEDLINE/PubMed |
spelling | pubmed-81090842021-05-12 Transcriptome integration analysis and specific diagnosis model construction for Hodgkin's lymphoma, diffuse large B-cell lymphoma, and mantle cell lymphoma Li, Wen-Xing Dai, Shao-Xing An, San-Qi Sun, Tingting Liu, Justin Wang, Jun Liu, Leyna G. Xun, Yang Yang, Hua Fan, Li-Xia Zhang, Xiao-Li Liao, Wan-Qin You, Hua Tamagnone, Luca Liu, Fang Huang, Jing-Fei Liu, Dahai Aging (Albany NY) Research Paper Transcriptome differences between Hodgkin's lymphoma (HL), diffuse large B-cell lymphoma (DLBCL), and mantle cell lymphoma (MCL), which are all derived from B cell, remained unclear. This study aimed to construct lymphoma-specific diagnostic models by screening lymphoma marker genes. Transcriptome data of HL, DLBCL, and MCL were obtained from public databases. Lymphoma marker genes were screened by comparing cases and controls as well as the intergroup differences among lymphomas. A total of 9 HL marker genes, 7 DLBCL marker genes, and 4 MCL marker genes were screened in this study. Most HL marker genes were upregulated, whereas DLBCL and MCL marker genes were downregulated compared to controls. The optimal HL-specific diagnostic model contains one marker gene (MYH2) with an AUC of 0.901. The optimal DLBCL-specific diagnostic model contains 7 marker genes (LIPF, CCDC144B, PRO2964, PHF1, SFTPA2, NTS, and HP) with an AUC of 0.951. The optimal MCL-specific diagnostic model contains 3 marker genes (IGLV3-19, IGKV4-1, and PRB3) with an AUC of 0.843. The present study reveals the transcriptome data-based differences between HL, DLBCL, and MCL, when combined with other clinical markers, may help the clinical diagnosis and prognosis. Impact Journals 2021-04-22 /pmc/articles/PMC8109084/ /pubmed/33885377 http://dx.doi.org/10.18632/aging.202882 Text en Copyright: © 2021 Li et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/3.0/) (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Paper Li, Wen-Xing Dai, Shao-Xing An, San-Qi Sun, Tingting Liu, Justin Wang, Jun Liu, Leyna G. Xun, Yang Yang, Hua Fan, Li-Xia Zhang, Xiao-Li Liao, Wan-Qin You, Hua Tamagnone, Luca Liu, Fang Huang, Jing-Fei Liu, Dahai Transcriptome integration analysis and specific diagnosis model construction for Hodgkin's lymphoma, diffuse large B-cell lymphoma, and mantle cell lymphoma |
title | Transcriptome integration analysis and specific diagnosis model construction for Hodgkin's lymphoma, diffuse large B-cell lymphoma, and mantle cell lymphoma |
title_full | Transcriptome integration analysis and specific diagnosis model construction for Hodgkin's lymphoma, diffuse large B-cell lymphoma, and mantle cell lymphoma |
title_fullStr | Transcriptome integration analysis and specific diagnosis model construction for Hodgkin's lymphoma, diffuse large B-cell lymphoma, and mantle cell lymphoma |
title_full_unstemmed | Transcriptome integration analysis and specific diagnosis model construction for Hodgkin's lymphoma, diffuse large B-cell lymphoma, and mantle cell lymphoma |
title_short | Transcriptome integration analysis and specific diagnosis model construction for Hodgkin's lymphoma, diffuse large B-cell lymphoma, and mantle cell lymphoma |
title_sort | transcriptome integration analysis and specific diagnosis model construction for hodgkin's lymphoma, diffuse large b-cell lymphoma, and mantle cell lymphoma |
topic | Research Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8109084/ https://www.ncbi.nlm.nih.gov/pubmed/33885377 http://dx.doi.org/10.18632/aging.202882 |
work_keys_str_mv | AT liwenxing transcriptomeintegrationanalysisandspecificdiagnosismodelconstructionforhodgkinslymphomadiffuselargebcelllymphomaandmantlecelllymphoma AT daishaoxing transcriptomeintegrationanalysisandspecificdiagnosismodelconstructionforhodgkinslymphomadiffuselargebcelllymphomaandmantlecelllymphoma AT ansanqi transcriptomeintegrationanalysisandspecificdiagnosismodelconstructionforhodgkinslymphomadiffuselargebcelllymphomaandmantlecelllymphoma AT suntingting transcriptomeintegrationanalysisandspecificdiagnosismodelconstructionforhodgkinslymphomadiffuselargebcelllymphomaandmantlecelllymphoma AT liujustin transcriptomeintegrationanalysisandspecificdiagnosismodelconstructionforhodgkinslymphomadiffuselargebcelllymphomaandmantlecelllymphoma AT wangjun transcriptomeintegrationanalysisandspecificdiagnosismodelconstructionforhodgkinslymphomadiffuselargebcelllymphomaandmantlecelllymphoma AT liuleynag transcriptomeintegrationanalysisandspecificdiagnosismodelconstructionforhodgkinslymphomadiffuselargebcelllymphomaandmantlecelllymphoma AT xunyang transcriptomeintegrationanalysisandspecificdiagnosismodelconstructionforhodgkinslymphomadiffuselargebcelllymphomaandmantlecelllymphoma AT yanghua transcriptomeintegrationanalysisandspecificdiagnosismodelconstructionforhodgkinslymphomadiffuselargebcelllymphomaandmantlecelllymphoma AT fanlixia transcriptomeintegrationanalysisandspecificdiagnosismodelconstructionforhodgkinslymphomadiffuselargebcelllymphomaandmantlecelllymphoma AT zhangxiaoli transcriptomeintegrationanalysisandspecificdiagnosismodelconstructionforhodgkinslymphomadiffuselargebcelllymphomaandmantlecelllymphoma AT liaowanqin transcriptomeintegrationanalysisandspecificdiagnosismodelconstructionforhodgkinslymphomadiffuselargebcelllymphomaandmantlecelllymphoma AT youhua transcriptomeintegrationanalysisandspecificdiagnosismodelconstructionforhodgkinslymphomadiffuselargebcelllymphomaandmantlecelllymphoma AT tamagnoneluca transcriptomeintegrationanalysisandspecificdiagnosismodelconstructionforhodgkinslymphomadiffuselargebcelllymphomaandmantlecelllymphoma AT liufang transcriptomeintegrationanalysisandspecificdiagnosismodelconstructionforhodgkinslymphomadiffuselargebcelllymphomaandmantlecelllymphoma AT huangjingfei transcriptomeintegrationanalysisandspecificdiagnosismodelconstructionforhodgkinslymphomadiffuselargebcelllymphomaandmantlecelllymphoma AT liudahai transcriptomeintegrationanalysisandspecificdiagnosismodelconstructionforhodgkinslymphomadiffuselargebcelllymphomaandmantlecelllymphoma |